https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:25828 Wed 02 Mar 2022 14:24:33 AEDT ]]> Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:26225 Fri 03 Dec 2021 10:33:00 AEDT ]]>